Requirement of phosphorylatable endothelial nitric oxide synthase at Ser-1177 for vasoinhibin-mediated inhibition of endothelial cell migration and proliferation in vitro

Endocrine

Volumn 45, Issue 2, 2014, Pages 263-270

  García, Celina ^a   Nuñez Anita, Rosa Elvira ^a   Thebault, Stéphanie ^a   Arredondo Zamarripa, David ^a   Jeziorsky, Michael C ^a   Martínez De La Escalera, Gonzalo ^a   Clapp, Carmen ^a  

^a INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

Author keywords

16K prolactin; Endothelial cell proliferation; Endothelial nitric oxide synthase; Migration; Vasoinhibins

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; PROLACTIN; SERINE; UNCLASSIFIED DRUG; VASOINHIBIN;

ANIMAL CELL; ARTICLE; CATTLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; HORMONE ACTION; IN VITRO STUDY; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL; WILD TYPE;

ALANINE; ANIMALS; CATTLE; CELL CYCLE PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; MODELS, ANIMAL; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; RECOMBINANT PROTEINS; SERINE; TRANSFECTION;

EID: 84896733866     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-9964-4     Document Type: Article

References (49)

1. L.J. Ignarro, Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ. Res. 65, 1-21 (1989)
2. G. Walford, J. Loscalzo, Nitric oxide in vascular biology. J. Thromb. Haemost. 1, 2112-2118 (2003)
3. D. Fukumura, T. Gohongi, A. Kadambi, Y. Izumi, J. Ang, C.O. Yun, D.G. Buerk, P.L. Huang, R.K. Jain, Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc. Natl Acad. Sci. USA 98, 2604-2609 (2001)
4. C. Morais, Q. Ebrahem, B. Anand-Apte, M.O. Parat, Altered angiogenesis in caveolin-1 gene-deficient mice is restored by ablation of endothelial nitric oxide synthase. Am. J. Pathol. (2012). doi: 10.1016/j.ajpath.2011.12.018
5. G. Cirino, S. Fiorucci, W.C. Sessa, Endothelial nitric oxide synthase: the Cinderella of inflammation? Trends Pharmacol. Sci. 24, 91-95 (2003)
6. H. Li, U. Forstermann, Prevention of atherosclerosis by interference with the vascular nitric oxide system. Curr. Pharm. Des. 15, 3133-3145 (2009)
7. J.A. Panza, C.E. Garcia, C.M. Kilcoyne, A.A. Quyyumi, R.O. Cannon 3rd, Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 91, 1732-1738 (1995)
8. C.R. Triggle, H. Ding, A review of endothelial dysfunction in diabetes: a focus on the contribution of a dysfunctional eNOS. J. Am. Soc. Hypertens. 4, 102-115 (2010)
9. P.L. Huang, Z. Huang, H. Mashimo, K.D. Bloch, M.A. Moskowitz, J.A. Bevan, M.C. Fishman, Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377, 239-242 (1995)
10. J.E. Freedman, R. Sauter, E.M. Battinelli, K. Ault, C. Knowles, P.L. Huang, J. Loscalzo, Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene. Circ. Res. 84, 1416-1421 (1999)
11. P. Sonveaux, P. Martinive, J. DeWever, Z. Batova, G. Daneau, M. Pelat, P. Ghisdal, V. Gregoire, C. Dessy, J.L. Balligand, O. Feron, Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hind limb collateralization and nitric oxide-mediated angiogenesis. Circ. Res. 95, 154-161 (2004)
12. T.J. McCabe, D. Fulton, L.J. Roman, W.C. Sessa, Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation. J. Biol. Chem. 275, 6123-6128 (2000)
13. D.N. Atochin, A. Wang, V.W. Liu, J.D. Critchlow, A.P. Dantas, R. Looft-Wilson, T. Murata, S. Salomone, H.K. Shin, C. Ayata, M.A. Moskowitz, T. Michel, W.C. Sessa, P.L. Huang, The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J. Clin. Invest. 117, 1961-1967 (2007)
14. R.C. Venema, Post-translational mechanisms of endothelial nitric oxide synthase regulation by bradykinin. Int. Immunopharmacol. 2, 1755-1762 (2002)
15. K. Hisamoto, M. Ohmichi, H. Kurachi, J. Hayakawa, Y. Kanda, Y. Nishio, K. Adachi, K. Tasaka, E. Miyoshi, N. Fujiwara, N. Taniguchi, Y. Murata, Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J. Biol. Chem. 276, 3459-3467 (2001)
16. S. Dimmeler, E. Dernbach, A.M. Zeiher, Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett. 477, 258-262 (2000)
17. F. Kim, B. Gallis, M.A. Corson, TNF-alpha inhibits flow and insulin signaling leading to NO production in aortic endothelial cells. Am. J. Physiol. Cell Physiol. 280, C1057-C1065 (2001)
18. Y.H. Shen, L. Zhang, Y. Gan, X. Wang, J. Wang, S.A. LeMaire, J.S. Coselli, X.L. Wang, Up-regulation of PTEN (phosphatase and tensin homolog deleted on chromosome ten) mediates p38 MAPK stress signal-induced inhibition of insulin signaling. A cross-talk between stress signaling and insulin signaling in resistin-treated human endothelial cells. J. Biol. Chem. 281, 7727-7736 (2006)
19. C. Garcia, J. Aranda, E. Arnold, S. Thebault, Y. Macotela, F. Lopez-Casillas, V. Mendoza, H. Quiroz-Mercado, H.L. Hernandez-Montiel, S.H. Lin, G. Martínez de la Escalera, C. Clapp, Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation. J. Clin. Invest. 118, 2291-2300 (2008)
20. C. Urbich, A. Reissner, E. Chavakis, E. Dernbach, J. Haendeler, I. Fleming, A.M. Zeiher, M. Kaszkin, S. Dimmeler, Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin. FASEB J. 16, 706-708 (2002)
21. C. Clapp, J. Aranda, C. Gonzalez, M.C. Jeziorski, G. Martínez de la Escalera, Vasoinhibins: endogenous regulators of angiogenesis and vascular function. Trends Endocrinol. Metab. 17, 301-307 (2006)
22. C. Clapp, S. Thebault, M.C. Jeziorski, G. Martínez de la Escalera, Peptide hormone regulation of angiogenesis. Physiol. Rev. 89, 1177-1215 (2009)
23. J. Triebel, M. Huefner, G. Ramadori, Investigation of prolactin-related vasoinhibin in sera from patients with diabetic retinopathy. Eur. J. Endocrinol. 161, 345-353 (2009)
24. C. Gonzalez, A.M. Corbacho, J.P. Eiserich, C. Garcia, F. Lopez-Barrera, V. Morales-Tlalpan, A. Barajas-Espinosa, M. Diaz-Munoz, R. Rubio, S.H. Lin, G. Martínez de la Escalera, C. Clapp, 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation. Endocrinology 145, 5714-5722 (2004)
25. C. Clapp, J.A. Martial, R.C. Guzman, F. Rentier-Delure, R.I. Weiner, The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133, 1292-1299 (1993)
26. S.H. Lee, J. Kunz, S.H. Lin, L.Y. Yu-Lee, 16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras-Tiam1-Rac1-Pak1 signaling pathway. Cancer Res. 67, 11045-11053 (2007)
27. M. Schleicher, J. Yu, T. Murata, B. Derakhshan, D. Atochin, L. Qian, S. Kashiwagi, A. Di Lorenzo, K.D. Harrison, P.L. Huang, W.C. Sessa, The Akt1-eNOS axis illustrates the specificity of kinase-substrate relationships in vivo. Sci. Signal 2, ra41 (2009)
28. M. Galfione, W. Luo, J. Kim, D. Hawke, R. Kobayashi, C. Clapp, L.Y. Yu-Lee, S.H. Lin, Expression and purification of the angiogenesis inhibitor 16-kDa prolactin fragment from insect cells. Protein Expr. Purif. 28, 252-258 (2003)
29. S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse, A.M. Zeiher, Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399, 601-605 (1999)
30. M. Cajero-Juarez, B. Avila, A. Ochoa, E. Garrido-Guerrero, A. Varela-Echavarria, G. Martínez de la Escalera, C. Clapp, Immortalization of bovine umbilical vein endothelial cells: a model for the study of vascular endothelium. Eur. J. Cell Biol. 81, 1-8 (2002)
31. F. Colbere-Garapin, A.C. Garapin, Gene transfer into mammalian cells. Dev. Biol. Stand. 55, 267-271 (1983)
32. C.C. Liang, A.Y. Park, J.L. Guan, In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2, 329-333 (2007)
33. A.G. Herman, S. Moncada, Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis. Eur. Heart J. 26, 1945-1955 (2005)
34. M. Vasa, K. Breitschopf, A.M. Zeiher, S. Dimmeler, Nitric oxide activates telomerase and delays endothelial cell senescence. Circ. Res. 87, 540-542 (2000)
35. R. Rafikov, F.V. Fonseca, S. Kumar, D. Pardo, C. Darragh, S. Elms, D. Fulton, S.M. Black, eNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity. J. Endocrinol. 210, 271-284 (2011)
36. R.S. Scotland, M. Morales-Ruiz, Y. Chen, J. Yu, R.D. Rudic, D. Fulton, J.P. Gratton, W.C. Sessa, Functional reconstitution of endothelial nitric oxide synthase reveals the importance of serine 1179 in endothelium-dependent vasomotion. Circ. Res. 90, 904-910 (2002)
37. I.T. Demchenko, D.N. Atochin, D.R. Gutsaeva, R.R. Godfrey, P.L. Huang, C.A. Piantadosi, B.W. Allen, Contributions of nitric oxide synthase isoforms to pulmonary oxygen toxicity, local vs. mediated effects. Am. J. Physiol. Lung Cell Mol. Physiol. 294, L984-L990 (2008)
38. S. Takahashi, T. Shinya, A. Sugiyama, Angiostatin inhibition of vascular endothelial growth factor-stimulated nitric oxide production in endothelial cells. J. Pharmacol. Sci. 112, 432-437 (2010)
39. E.M. Bauer, Y. Qin, T.W. Miller, R.W. Bandle, G. Csanyi, P.J. Pagano, P.M. Bauer, J. Schnermann, D.D. Roberts, J.S. Isenberg, Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation. Cardiovasc. Res. 88, 471-481 (2010)
40. S. Thebault, C. González, C. García, D. Arredondo Zamarripa, G. Nava, L. Vaca, F. López-Casillas, G. Martínez de la Escalera, C. Clapp, Vasoinhibins prevent bradykinin-stimulated endothelial cell proliferation by inactivating eNOS via reduction of both intracellular Ca2+ levels and eNOS phosphorylation at Ser1179. Pharmaceuticals 4, 1052-1069 (2011)
41. B.J. Michell, J.E. Griffiths, K.I. Mitchelhill, I. Rodriguez-Crespo, T. Tiganis, S. Bozinovski, P.R. de Montellano, B.E. Kemp, R.B. Pearson, The Akt kinase signals directly to endothelial nitric oxide synthase. Curr. Biol. 9, 845-848 (1999)
42. H. Cai, D. Liu, J.G. Garcia, CaM Kinase II-dependent pathophysiological signalling in endothelial cells. Cardiovasc. Res. 77, 30-34 (2008)
43. C. Clapp, R.I. Weiner, A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells. Endocrinology 130, 1380-1386 (1992)
44. H. Suzuki, K. Kimura, H. Shirai, K. Eguchi, S. Higuchi, A. Hinoki, K. Ishimaru, E. Brailoiu, D.N. Dhanasekaran, L.N. Stemmle, T.A. Fields, G.D. Frank, M.V. Autieri, S. Eguchi, Endothelial nitric oxide synthase inhibits G12/13 and rho-kinase activated by the angiotensin II type-1 receptor: implication in vascular migration. Arterioscler. Thromb. Vasc. Biol. 29, 217-224 (2009)
45. G. D'Angelo, I. Struman, J. Martial, R.I. Weiner, Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc. Natl Acad. Sci. USA 92, 6374-6378 (1995)
46. M. Ziche, L. Morbidelli, Nitric oxide and angiogenesis. J. Neurooncol. 50, 139-148 (2000)
47. D.M. Dudzinski, T. Michel, Life history of eNOS: partners and pathways. Cardiovasc. Res. 75, 247-260 (2007)
48. D. Hilfiker-Kleiner, K. Kaminski, E. Podewski, T. Bonda, A. Schaefer, K. Sliwa, O. Forster, A. Quint, U. Landmesser, C. Doerries, M. Luchtefeld, V. Poli, M.D. Schneider, J.L. Balligand, F. Desjardins, A. Ansari, I. Struman, N.Q. Nguyen, N.H. Zschemisch, G. Klein, G. Heusch, R. Schulz, A. Hilfiker, H. Drexler, A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128, 589-600 (2007)
49. C. Gonzalez, A. Parra, J. Ramirez-Peredo, C. Garcia, J.C. Rivera, Y. Macotela, J. Aranda, M. Lemini, J. Arias, F. Ibarguengoitia, G. Martínez de la Escalera, C. Clapp, Elevated vasoinhibins may contribute to endothelial cell dysfunction and low birth weight in preeclampsia. Lab. Invest. 87, 1009-1017 (2007)